ClinicalTrials.govpublic full text
Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation
graft-versus-host disease, hematopoietic stem cell transplantation, gvhd, maraviroc, non-myeloablative allogeneic stem-cell transplantation, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 843975
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.